Results 31 to 40 of about 5,629,397 (283)

Pathway analysis of intrauterine growth restriction.

, 2019
Pathway analysis of intrauterine growth restriction.
Stewart F. Graham (710687), Ali Yilmaz (1430095), Andrew Mrazik (6612017), Ray Oliver Bahado-Singh (6612014), Eric Sherman (3913357), Anthony Odibo (6612020), Onur Turkoglu (804908), Halil Bisgin (3163854), Praveen Kumar (8242)   +8 more
core   +1 more source

The effect of darbepoetin alfa on the glomerulus of new-born mice with intrauterine growth restriction [PDF]

Srpski Arhiv za Celokupno Lekarstvo
Introduction/Objective. Intrauterine growth restriction is a condition in which a fetus is not able to achieve its genetic potential for growth. It has been linked with diseases of adulthood, such as hypertension, insulin-independent diabetes mellitus ...
Milojković Milica, Stojanović Vesna, Barišić Nenad   +2 more
doaj   +1 more source

Intrauterine Growth Restriction: Prevalence Rate, Associated Risk Factors and Perinatal Outcomes at Maternity Teaching Hospital in Erbil/Iraq

Advanced Medical Journal
Background and objectives: Intrauterine growth restriction is well known cause for fetal morbidity and mortality all over the world especially in developing countries.
Sanarya Jafa Jamal, Ariana Khalis Jawad   +1 more
doaj   +1 more source

Reduced placental telomere length during pregnancies complicated by intrauterine growth restriction. [PDF]

PLoS ONE, 2013
OBJECTIVES: Recent studies have shown that telomere length was significantly reduced in placentas collected at delivery from pregnancies complicated by intrauterine growth restriction secondary to placental insufficiency.
Jérôme Toutain, Martina Prochazkova-Carlotti, David Cappellen, Ana Jarne, Edith Chevret, Jacky Ferrer, Yamina Idrissi, Fanny Pelluard, Dominique Carles, Brigitte Maugey-Laulon, Didier Lacombe, Jacques Horovitz, Jean-Philippe Merlio, Robert Saura   +13 more
doaj   +1 more source

Intrauterine growth restriction and placental angiogenesis

Diagnostic Pathology, 2010
Background Vascular endothelial growth factor (VEGF), basic-fibroblast growth factor (b-FGF), and endothelial nitric oxide synthase (eNOS) are factors that take part in placental angiogenesis.
Harma Muge, Harma Mehmet, Kandemir Nilufer, Gun Banu, Barut Aykut, Barut Figen, Aktunc Erol, Ozdamar Sukru   +7 more
doaj   +1 more source

NSUN2‐Mediated m5C Modification of TGFB1 in Trophoblasts Remodels Macrophage Function to Prevent URSA

Advanced Science, EarlyView.
NSUN2 and m5C decline in URSA villous tissues. Trophoblast Nsun2 ablation disrupts macrophage‐mediated maternal‐fetal tolerance and triggers embryo resorption. Mechanistically, NSUN2‐YBX1 axis stabilizes m5C‐modified TGFB1 mRNA to maintain TGF‐β1 secretion and M2 polarization, and restoring this signaling rescues maternal‐fetal immune tolerance to ...
Xiaoxiao Zhu, Xinkui Liu, Xiaoyan Yu, Qiaoqiao Han, Feifei Shi, Weiwei Song, Lu Liu, Chu Chu, Chenyang Shen, Zhen Zhang, Xia Li   +10 more
wiley   +1 more source

The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia

, 2011
To evaluate the oxidative state of lipoproteins in pregnancies complicated by intrauterine growth restriction (IUGR) in comparison to preeclampsia (PE) and healthy pregnant control subjects (CN)
Ulrich Pecks, Raphaela Caspers, Caspers, Raphaela Charlotte Alexandra, Piroth, Daniela Melanie, Pecks, Ulrich, Maass, Nicolai, Daniela Piroth, Nicolai Maass, Piroth, Daniela, Caspers, Raphaela, Dirk Bauerschlag, Rath, Werner, Werner Rath, Schiessl, Barbara, Barbara Schiessl, Bauerschlag, Dirk   +15 more
core   +1 more source

Genetics Etiologies Associated with Fetal Growth Restriction

Maternal-Fetal Medicine, 2022
. Fetal growth restriction (FGR) is associated with multiple adverse perinatal outcomes, such as increased risk of intrauterine death, neonatal morbidity and mortality, and long-term adverse outcomes.
Dayuan Shi, Luyao Cai, Luming Sun, Dandan Shi   +3 more
doaj   +1 more source

An Injectable, Self‐Expanding Hemostatic Foam for Field‐Compatible Postpartum Hemorrhage Management

Advanced Science, EarlyView.
Postpartum hemorrhage is the leading cause of maternal death worldwide, yet many treatments are hard to use outside well‐equipped hospitals. This work introduces an easy‐to‐use device that rapidly delivers a degradable foam into the uterus. The foam stops bleeding through pressure and clotting support, offering a practical option for low‐resource ...
Charlotte Meyer, Noël Strasser, Ilakkiya Ravindrarajah, Elsa Wrenger, Kristian Ivkovic, Jan Ševčík, Sima Šarčević, Lenka Červenková, Jáchym Rosendorf, Václav Liška, Alexandre H. Anthis, Thomas Rduch, Inge K. Herrmann   +12 more
wiley   +1 more source

Intrauterine Growth Restriction Associated with Hematologic Abnormalities: Probable Manifestations of Placental Mesenchymal Dysplasia

American Journal of Perinatology Reports, 2015
Introduction Placental mesenchymal dysplasia is a rare vascular disease associated with intrauterine growth restriction, fetal demise as well as Beckwith–Wiedemann syndrome.
Cristina Martinez-Payo, Rocio Alvarez Bernabeu, Isabel Salas Villar, Enrique Iglesias Goy   +3 more
doaj   +1 more source